Dangers of exposure to ‚white‘ light

New study reveals: ‚White‘ light suppresses the body’s production of melatonin — a compound that adjusts our biological clock and is known for its anti-oxidant and anti-cancerous properties — more than orange light

 

Haifa, Israel (September 12, 2011) – Exposure to the light of white LED bulbs, it turns out, suppresses melatonin 5 times more than exposure to the light of High Pressure Sodium bulbs that give off an orange-yellow light. "Just as there are regulations and standards for ‚classic‘ pollutants, there should also be regulations and rules for the pollution stemming from artificial light at night," says Prof. Abraham Haim of the University of Haifa.

 

"White" light bulbs that emit light at shorter wavelengths are greater suppressors of the body’s production of melatonin than bulbs emitting orange-yellow light, a new international study has revealed.

 

Melatonin is a compound that adjusts our biological clock and is known for its anti-oxidant and anti-cancerous properties.

 

The study investigated the influence of different types of bulbs on "light pollution" and the suppression of melatonin, with the researchers recommending several steps that should be taken to balance the need to save energy and protecting public health.

 

"Just as there are regulations and standards for ‚classic‘ pollutants, there should also be regulations and rules for pollution stemming from artificial light at night," says Prof. Abraham Haim, head of the Center for Interdisciplinary Chronobiological Research at the University of Haifa and the Israeli partner in the research.

 

The study, titled "Limiting the impact of light pollution on human health, environment and stellar visibility" by Fabio Falchi, Pierantonio Cinzano, Christopher D. Elvidge, David M. Keith and Abraham Haim, was recently published in the Journal of Environmental Management.

 

The fact that "white" artificial light (which is actually blue light on the spectrum, emitted at wavelengths of between 440-500 nanometers) suppresses the production of melatonin in the brain’s pineal gland is already known. Also known is the fact that suppressing the production of melatonin, which is responsible, among other things, for the regulation of our biological clock, causes behavior disruptions and health problems.

 

In this study, conducted by astronomers, physicists and biologists from ISTIL- Light Pollution Science and Technology Institute in Italy, the National Geophysical Data Center in Boulder, Colorado, and the University of Haifa, researchers for the first time examined the differences in melatonin suppression in a various types of light bulbs, primarily those used for outdoor illumination, such as streetlights, road lighting, mall lighting and the like.

 

In the first, analytical part of the study, the researchers, relying on various data, calculated the wavelength and energy output of bulbs that are generally used for outdoor lighting. Next, they compared that information with existing research regarding melatonin suppression to determine the melatonin suppression level of each bulb type.

 

Taking into account the necessity for artificial lighting in cities, as well as the importance of energy-saving bulbs, the research team took as a reference point the level of melatonin suppression by a high-pressure sodium (HPS) bulb, a bulb that gives off orange-yellow light and is often used for street and road lighting, and compared the data from the other bulbs to that one.

 

From this comparison it emerged that the metal halide bulb, which gives off a white light and is used for stadium lighting, among other uses, suppresses melatonin at a rate more than 3 times greater than the HPS bulb, while the light-emitting diode (LED) bulb, which also gives off a white light, suppresses melatonin at a rate more than 5 times higher than the HPS bulb.

 

"The current migration from the now widely used sodium lamps to white lamps will increase melatonin suppression in humans and animals," the researchers say.

 

The researchers make some concrete suggestions that could alter the situation without throwing our world into total darkness, but first and foremost, they assert that it is necessary to understand that artificial light creates "light pollution" that ought to be addressed in the realms of regulation and legislation.

 

Their first suggestion of course, is to limit the use of "white" light to those instances where it is absolutely necessary. Another suggestion is to adjust lampposts so that their light is not directed beyond the horizon, which would significantly reduce light pollution. They also advise against "over-lighting", using only the amount of light needed for a task, and, of course, to simply turn off lighting when not in use – "Just like we all turn off the light when we leave the room. This is the first and primary way to save energy," the researchers say.

 

"Most Italian regions have legislations to lower the impact of light pollution, but they still lack a regulation on the spectrum emitted by lamps. Unless legislation is updated soon, with the current trend toward sources as white LEDs, which emit a huge amount of blue light, we will enter a period of elevated negative effects of light at night on human health and environment. Lamp manufacturers cannot claim that they don’t know about the consequences of artificial light at night," says Dr. Fabio Falchi of ISTIL.

 

"As a first step in Israel, for example, the Standards Institution of Israel should obligate bulb importers to state clearly on their packaging what wavelengths are produced by each bulb. If wavelength indeed influences melatonin production, this is information that needs to be brought to the public’s attention, so consumers can decide whether to buy this lighting or not," Prof. Haim says.

 

 


University of Haifa, 12.09.2011 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…